По вашему запросу найдено документов: 353

Страница 1 из 36

and children. The present trial was a safety and dose-finding study for weekly MOD-4023 in GHD children. Design

-weekly subcutaneous (SC) administration of MOD-4023 were assessed in children with GHD over a period of 24 months

-term safety and efficacy of once-weekly lonapegsomatropin in children with growth hormone deficiency (GHD

-weekly treatment for children with GH deficiency (GHD). A 12-month, phase 2 study of once-weekly somatrogon vs

for once-weekly treatment of children with growth hormone deficiency (GHD). Objective: We aimed to compare

and children with GH deficiency (GHD). This study was designed to compare 12-month effects of once

-release human GH prodrug in development for children with GH deficiency (GHD). Objective: To compare

Objective: To analyze the profile of sensitization to airborne allergens in children with atopic

AND METHODS: The study included 51 children. 40 (78.4%) of them had combined lesion of liver and other organs

and hematopoietic apparatus in children at the early stages of their formation, the risk factors for the development

Страница 1 из 36